Figures & data
Table 1. General population, no a priori exposure, in µg/L (ppb).
Table 2. Bystanders and rural populations, source of exposure expected to be indirect, in µg/L (ppb).
Table 3. Applicators, source of exposure expected to be direct, in µg/L (ppb).
Table 4. Carcinogenicity: summary of findings of 2,4-D exposure and cancer.
Table 5. Reproductive toxicity: summary of findings of 2,4-D exposure and reproductive endpoints.
Table 6. Genotoxicity: summary of findings of 2,4-D exposure and genetic, hormone, and immune related endpoints.
Table 7. Neurotoxicity.
Table 8. General toxicity.
Figure 1. Relative risk estimates, lower and upper limits for epidemiology studies of NHL from 1989 to 2011.
![Figure 1. Relative risk estimates, lower and upper limits for epidemiology studies of NHL from 1989 to 2011.](/cms/asset/6cb45b9d-dbb3-489c-ad60-29bba3a711df/itxc_a_710576_f0001_b.gif)
Table 9. Comparison of results in an epidemiology study.